PMDA — authorised 26 March 2019
- Marketing authorisation holder: CLINIGEN K.K.
- Status: approved
🇯🇵 Foscavir in Japan
PMDA authorised Foscavir on 26 March 2019
Marketing authorisation
Foscavir in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Foscavir approved in Japan?
Yes. PMDA authorised it on 26 March 2019.
Who is the marketing authorisation holder for Foscavir in Japan?
CLINIGEN K.K. holds the Japanese marketing authorisation.